Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Evonik Industries AG

Start price
Target price
Perf. (%)
€27.88
16.12.21
-
16.12.22
2.51%
24.01.22

Could be worthwhile Investment >10% per year
buy
Mexichem SAB de CV

Start price
Target price
Perf. (%)
€1.77
14.12.21
€2.40
-
04.03.23

Could be worthwhile Investment >10% per year
buy
Neogen Corp.

Start price
Target price
Perf. (%)
€35.40
14.12.21
€38.00
14.12.22
-59.89%
15.12.22

Could be worthwhile Investment >10% per year
buy
Lundin Mining Corp.

Start price
Target price
Perf. (%)
€7.52
13.12.21
-
13.12.25
-16.10%
03.04.23

Could be worthwhile Investment >10% per year
Arena Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€81.50
13.12.21
-
13.12.22
1.23%
06.01.22

Probably not worthwhile Investment
buy
Arkema S.A.

Start price
Target price
Perf. (%)
€118.15
13.12.21
€125.00
13.12.22
-26.79%
14.12.22

Could be worthwhile Investment >10% per year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€239.00
13.12.21
€230.00
13.12.22
-30.02%
14.12.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
ON Semiconductor Corp

Start price
Target price
Perf. (%)
€59.06
13.12.21
€65.00
13.12.22
10.06%
14.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
High valuation
buy
Pan American Silver Corp.

Start price
Target price
Perf. (%)
€21.03
13.12.21
-
13.12.22
4.14%
25.12.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Tilray Inc

Start price
Target price
Perf. (%)
€7.65
13.12.21
-
13.12.22
-56.81%
14.12.22

Could be very worthwhile Investment >20% year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€8.47
13.12.21
-
13.12.22
-67.06%
14.12.22

Could be very worthwhile Investment >20% year
Revenue decline/stagnation expected
buy
Cronos Group Inc.

Start price
Target price
Perf. (%)
€3.79
13.12.21
-
13.12.22
-19.99%
24.01.22

Could be very worthwhile Investment >20% year
buy
Valneva SE ADR

Start price
Target price
Perf. (%)
€48.00
12.12.21
-
12.12.22
8.33%
25.12.21

Could be very worthwhile Investment >20% year
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€238.20
12.12.21
-
12.12.22
-4.28%
25.12.21

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
-
12.12.22
-3.13%
25.12.21

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€180.00
12.12.22
-32.76%
13.12.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
buy
Encavis AG

Start price
Target price
Perf. (%)
€15.25
12.12.21
€17.00
12.12.22
3.61%
25.12.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€260.00
12.12.22
-3.13%
25.12.21

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€238.20
12.12.21
€260.00
12.12.22
-4.28%
25.12.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
Standard Investments for future growth
Capable Management
buy
GSW Immobilien AG

Start price
Target price
Perf. (%)
€114.00
11.12.21
€166.00
11.12.22
-20.70%
12.12.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
buy
Sociedad Quimica y Minera de Chile SA ADR

Start price
Target price
Perf. (%)
€52.00
11.12.21
€65.00
11.12.22
-14.23%
25.12.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€39.97
11.12.21
€43.00
11.12.22
-64.71%
12.12.22

Could be worthwhile Investment >10% per year
Peloton Interactive Inc.

Start price
Target price
Perf. (%)
€34.30
11.12.21
-
11.12.22
-65.47%
08.12.22

Probably not worthwhile Investment
BioNTech SE ADR

Start price
Target price
Perf. (%)
€229.40
10.12.21
-
10.12.22
-30.01%
11.12.22

Probably not worthwhile Investment
Very low/no dividend yield expected
Business model of the past or high risk
buy
TUI AG ADR

Start price
Target price
Perf. (%)
€1.25
10.12.21
€1.80
10.12.22
-18.40%
11.06.22

Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Growths slower than the competition
Very high cyclical dependencies